Our Organization is discussing the risk - benefit of carrying two different concentrations of Atropine injection (for Cardiac Resuscitation) versus two different sizes of the same concentration.
The health system is made up of several hospitals: one is a Pediatric Specialty Hospital, the others are general hospitals treating adult, pediatric and Neonatal patients (NICU).
Basically, the pharmacies all need to come to agreement on which products to stock, and a standard process to assure the intended product is only distributed to the intended Care Area.

Hi
Wondering if anyone has undergone a recent TJC survey. Interested in their stance on electronic vs "wet" signatures in the employees file. Example would be sterile compounding requirements.
Is it necessary to have entire file in a paper folder, or is it OK to use a hybrid of password-protected retrievable databases (i.e. Simplifi 797) and a note in the file that all USP 797 requirements are maintained electronically with the employee's signed acknowledgement? Trying to conserve paper but do not want to be out of compliance while in TJC window.

Hello everyone,

I need support if any of you have updated policy or guidelines related to COVID19 patient's returned medications in your practice?
Especially medication safety officer in gulf area
Thank you for your help

Hi Everyone,

I am reaching out hoping to find out what other institutions are doing in regards to insulin dosing prior to surgeries/procedures for patients who are NPO? What methods do you use to prompt nursing to reduce the dose?

Thanks,

Derek Pohlmeyer
PGY1 Pharmacy Administration Resident, UW Medicine

This is a topic that gets tricky for me to comprehend, so wondering if others could weigh in on whether I am on the right track or not....

When repackaging a sterile single dose container (for example, fluconazole RTU 200mg/100ml into two 100mg/50ml doses), do the repackaged doses get the same BUD as the SDC once opened? So 6 hours with previous 797, 12 hours with new 797?

What if the container is not labeled for single dose or multi-dose?

Does anyone have a process for disseminating updates to black box warnings to your prescribers? We have weighed the options we could think of and none are great. If we email all prescribers, it is spam to those who never prescribe the drug and email is ignored even by those for whom it would be relevant. If we target the email to specific departments, we run the risk of missing those outside the notified departments who also prescribe the drug. If we post it somewhere centrally, then it requires the prescriber to go there to look (not likely).

Good Morning,
We are trying to implement the guidelines for ALT in pediatric patients on hemodialysis. But ran into an issue where stability of the final product lacks any supporting data.
Our list for ALT is:
1. Vancomycin 5mG/mL + heparin 1000 units/mL
2. Gentamicin 1 mG/mL + heparin 1000 units/mL
3. Cefazolin 5 mG/mL + heparin 1000 units/mL

Biktarvy(R) (bictegravir, emtricitabine and tenofovir alafenamide) states that the drug needs to be dispensed in its orginal container. I checked Pharmacist's Letter and it said it was because of having a desiccant. I called Gilead and they said that all research on the drug has been done using it from its original container so they do not have any stability data outside of that packaging.

For those who have a unit-dose system, how do you handle the dispensing of Biktarvy(R) or other drugs whose labeling states to dispense in their original containers?

Our nurses utilize a Silent Knight in the med room to crush meds prior to administration but then struggle with bar code scanning if the bar code is no longer scannable after crushing or if the barcode is torn when opening prior to scanning. Any tips/tricks/best practices for crushed meds and barcode scanning?

Thanks!
Anna Schmidt